MedPath

Effect low dose ketamine in late brain injury from ruptured intracranial aneurysm

Phase 3
Conditions
Health Condition 1: I609- Nontraumatic subarachnoid hemorrhage, unspecified
Registration Number
CTRI/2023/04/051589
Lead Sponsor
ISNACC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.All aSAH patients 18-70 years of age

2.Admitted to the hospital within 72 hours of ictus

3.Ruptured anterior cerebral circulation aneurysm with subarachnoid hemorrhage on admission cranial computed tomography (CT) scan with modified Fisher grade of 3-4

4.World Federation of Neurological Surgeons (WFNS) grade 1 to 3

5.Informed Consent for participation in the study

Exclusion Criteria

1.Refusal of consent

2.Patients with multiple aneurysms

3.Baseline Systolic Blood Pressure (SBP) >200 mm Hg

4.Patients with intraoperative iatrogenic injury or inadvertent clipping of intracranial arteries

5.Any contraindication for the use of ketamine like acute psychosis, previous known ischemic heart diseases.

6.Mean arterial pressure (MAP) increases by more than 20% from baseline (on that day) following infusion

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath